2008Zhongguo linchuang yixueRequires access

Atorvastatin Combined with Ezetimibe in the Treatment of Patients with Hypercholesterolemia

Qibing Wang

Open publisher page 0 citations

Abstract

Objective:To investigate the efficacy of atorvastatin combined with ezetimibe in the treatment of patients with hypercholesterolemia.Methods:Forty patients(23 males,17 females,aged 58±12 yrs)with severe hypercholesterolemia who failed to achieve lipid lowering target level(LDL-C2.6 mmol/L)after 6 months treatment with atorvastatin(20mg,Qd)were added with ezetimibe(10 mg,Qd)for 3 months observation.Results:After 6 months treatment with atorvastatin,the lipids of TC,LDL-C,TG,ApoB and Lp(a)were decreased and HDL-C elevated remarkably than those at baseline,and with P0.01 respectively.When combined with ezetimibe for 3 months,the lipid level of TC,LDL-C and ApoB was reduced than that of merely using atorvastatin,and with P0.01 in respect.No significant abnormalities were found in particular with AST,ALT and CK during this therapy.Conclusion:Atorvastatin combined with ezetimibe can produce further lipid lowering effects than only atorvastatin in patient with severe hypercholesterolemia.

About this research paper

What this paper is about

Objective:To investigate the efficacy of atorvastatin combined with ezetimibe in the treatment of patients with hypercholesterolemia.Methods:Forty patients(23 males,17 females,aged 58±12 yrs)with severe hypercholesterolemia who failed to achieve lipid lowering target level(LDL-C2.6 mmol/L)after 6 months treatment with atorvastatin(20mg,Qd)were added with ezetimibe(10 mg,Qd)for 3 months observation.Results:After 6 months treatment with atorvastatin,the lipids of TC,LDL-C,TG,ApoB and Lp(a)were decreased and HDL-C elevated remarkably than those at baseline,and with P0.01 respectively.When combined with ezetimibe for 3 months,the lipid level of TC,LDL-C and ApoB was reduced than that of merely using atorvastatin,and with P0.01 in respect.No significant abnormalities were found in particular with AST,ALT and CK during this therapy.Conclusion:Atorvastatin combined with ezetimibe can produce further lipid lowering effects than only atorvastatin in patient with severe hypercholesterolemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the efficacy of atorvastatin combined with ezetimibe in the treatment of patients with hypercholesterolemia.Methods:Forty patients(23 males,17 females,aged 58±12 yrs)with severe hypercholesterolemia who failed to achieve lipid lowering target level(LDL-C2.6 mmol/L)after 6 months treatment with atorvastatin(20mg,Qd)were added with ezetimibe(10 mg,Qd)for 3 months observation.Results:After 6 months treatment with atorvastatin,the lipids of TC,LDL-C,TG,ApoB and Lp(a)were decreased and HDL-C elevated remarkably than those at baseline,and with P0.01 respectively.When combined with ezetimibe for 3 months,the lipid level of TC,LDL-C and ApoB was reduced than that of merely using atorvastatin,and with P0.01 in respect.No significant abnormalities were found in particular with AST,ALT and CK during this therapy.Conclusion:Atorvastatin combined with ezetimibe can produce further lipid lowering effects than only atorvastatin in patient with severe hypercholesterolemia.

Key concepts: Atorvastatin, Ezetimibe, Medicine, Apolipoprotein B, Internal medicine, Familial hypercholesterolemia, Ldl cholesterol, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Atorvastatin Combined with Ezetimibe in the Treatment of Patients with Hypercholesterolemia — Research Paper | ScholarLens